GASE Stock Falls Sharply On Recent News

Over two million shares have been taking part in today’s volume after GASE Energy informed stakeholders it has signed a second letter of intent to buy Sanatio Biosciences. The company probably has enough funds to expand in the biotech field while energy products seem to be cheap to offer while the renewable energy industry needs more funds than healthcare options.

Sanatio Bioscience has already been testing its candidates to fight covid-19 but its cancer therapeutics development program is most probably much feasible investment. Creating covid-19 vaccines has obviously become a “dead end” project after all the variants have been beating the vaccines up during multi-trillion injections into biotech projects. If GASE Energy successfully acquires Sanatio Bioscience the stock will blast off in a few minutes.